ATLASRexford Industrial Realty (REXR) earnings date: expected January 15–21
Rexford Industrial Realty (REXR) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 15–21. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on REXR
| Last price | $38.77 (+1.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.9% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
| Dividend | $1.74 a year (4.48% yield) |
These figures come from the same calibrated model and valuation as the Rexford Industrial Realty stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 15–21 (estimate). One email the day before, with ATLAS’s read on Rexford Industrial Realty. You can switch it off at any time.
Alert me before REXR reportsFree to start. Creating an account takes under a minute.
Notify me when Rexford Industrial Realty reports
Track REXR free Add Rexford Industrial Realty to a free ATLAS watchlist and see its next report date in one place.
REXR earnings at a glance
| Next report | Not announced · expected around January 15–21 (ATLAS estimate) |
|---|---|
| Last report | Oct 22, 2026 · In line |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +32.8% |
| Average move around a report | ±2.6% (last 5) |
| Sector | Real Estate · REIT - Industrial |
The expected window is an ATLAS estimate: it takes the typical gap between Rexford Industrial Realty’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Rexford Industrial Realty earnings history: last 5 reports
Rexford Industrial Realty last reported on Oct 22, 2026: EPS of $0.60 against an estimate of $0.60 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 22, 2026 | $0.60 | $0.60 | 0.0% | In line | +5.2% |
| Jul 20, 2026 | $0.34 | $0.36 | +5.9% | Beat | -0.9% |
| Apr 23, 2026 | $0.27 | $0.30 | +11.1% | Beat | -2.2% |
| Feb 16, 2026 | -$10.85 | -$0.59 | +94.6% | Beat | +0.1% |
| Feb 4, 2026 | $0.19 | $0.29 | +52.6% | Beat | -4.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for REXR
See the fair value, the probability range and the earnings history of Rexford Industrial Realty on its ATLAS page.
Rexford Industrial Realty (REXR) stock analysisPlans from €3.99 a month.
Rexford Industrial Realty earnings: frequently asked questions
When is Rexford Industrial Realty (REXR) next earnings date?
Rexford Industrial Realty has not announced its next report. Its last 4 reports came Oct 22, 2026, Jul 20, 2026, Apr 23, 2026, Feb 16, 2026, so ATLAS estimates the next one around January 15–21. This is an estimate based on that pattern, not a confirmed date.
How often does REXR beat earnings estimates?
Of its last 5 reports with a recorded result, Rexford Industrial Realty beat the EPS estimate 4 times; the average surprise was +32.8%. Past results do not predict the next one.
How much does REXR move around earnings?
Over its last 5 reports the stock moved an average of 2.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Rexford Industrial Realty beat earnings estimates last quarter?
Rexford Industrial Realty last reported on Oct 22, 2026: EPS of $0.60 against an estimate of $0.60 (0.0% surprise), in line with the estimate.
How much does REXR usually move in a day?
On a normal trading day the ATLAS model puts REXR’s one-day range at about ±1.9%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer